Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Argatroban

Argatroban synthesis

7synthesis methods
Argatroban is an anticoagulant that is a direct thrombin inhibitor. Argatroban was approved in 2000 for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). Argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site. Argatroban exerts its anticoagulant effects by inhibiting thrombin-catalyzed or -induced reactions, including fibrin formation; activation of coagulation factors V, VIII, and XIII; activation of protein C; and platelet aggregation. Argatroban inhibits thrombin with an inhibition constant (Ki) of 0.04 μM.
Synthetic Routes
  • ROUTE 1
  • 202112074667847072.jpg

    Libralon, Giovanna; Nicole, Andrea; Zanon, Jacopo. Method for the preparation of argatroban monohydrate. Assignee Lundbeck Pharmaceuticals Italy S.p.A.. 2008.

  • ROUTE 2
  • 202112077494798327.jpg

    Kikumoto, Ryoji. Method for the preparation of N2-arylsulfonyl-NG-nitro-L-arginines and their piperidinamide derivatives. Assignee Mitsubishi Chemical Corp. 1998.

  • ROUTE 3
  • 202112078714855096.jpg

    Liu, Jian; Li, Hongling; Ma, Yaping; Yuan, Jiancheng. Method for synthesizing argatroban through combination of solid-phase synthesis and liquid-phase synthesis. Assignee Shenzhen Hanyu Pharmaceutical Co., Ltd. Hybio Pharmaceutical Co., Ltd. 2009.

202112074667847072.jpg

Libralon, Giovanna; Nicole, Andrea; Zanon, Jacopo. Method for the preparation of argatroban monohydrate. Assignee Lundbeck Pharmaceuticals Italy S.p.A.. 2008.

-

Yield:74863-84-6 93%

Reaction Conditions:

with hydrogen;5%-palladium/activated carbon in methanol;acetic acid at 85; under 6375.64 Torr; for 8 h;Product distribution / selectivity;

Steps:

3

Example 2: treatment of the crude argatroban with NaOH and crystallization from normal propanolA one-litre glass autoclave was fed with 50 g of (2f?,4/:?)-1 -[NG-nitro-N2-(3-methyl- 8-quinolinesulphonyl)-L-arginyl]-4-methyl-2-piperidine carboxylic acid, 375 ml of methanol, 95 ml of acetic acid and 16.4 g of palladium on 5% carbon (60% wetted).The mixture thus obtained was treated, under vigorous stirring, at 85QC in a 8.5 bar hydrogen atmosphere for 8 hours. The mass was then cooled to room temperature and the catalyst removed by filtration. The obtained solution was concentrated to a residue under reduced pressure.570 ml of methylene chloride was added to the oily residue obtained and the solution divided into two parts. Half of the obtained solution was fed into a jacketed 1 -litre glass reactor and to it 120 ml of water were added. The acetic acid residue was then neutralized by addition of a 30% sodium hydroxide solution until pH=7.5 was achieved. In order to obtain a net separation between the organic phase and aqueous phase 12 ml of methanol were then added. The mixture was maintained under stirring for 1 hour, then the aqueous phase was removed and the organic phase washed twice with 120 ml of water, adding each time the necessary quantity of methanol to achieve a good separation.The solution in methylene chloride thus obtained was then percolated into a 500 ml jacketed reactor containing 140 ml of 1 -propanol. The mass was then heated to 55QC to distil off the dichloromethane present. The solution was then cooled to 0QC over a period of 2 hours and maintained at this temperature for 2 hours.The solid obtained by crystallization was filtered off and dried at 50QC under vacuum for 16 hours, giving 17.0 g of purified (2fl,4fl)-4-methyl-1 -[N2-[(1 ,2,3,4- tetrahydro-3-methyl-8- quinolylsulphonyl]-L-arginyl]pipecolic acid (IV). Yield = 73%. Example 3: treatment of crude argatroban without neutralization and with crystallization from isopropanolHalf of the compound (III) solution in dichloromethane obtained in example 2 was extracted twice with a mixture of 120 ml of water and 12 ml of methanol. The solution in methylene chloride thus obtained was then percolated into a 500 ml jacketed reactor containing 140 ml of 2-propanol, the mass obtained was concentrated by distillation.When the distillation was complete the temperature was brought to 90QC, the mass left under agitation for 1 hour, cooled to 20QC and finally to 0QC where it was maintained for 2 hours.The solid obtained by crystallization was filtered off and dried at 50QC under vacuum for 16 hours to give 21.5 g of purified (2fl,4fl)-4-methyl-1 -[N2-[(1 ,2,3,4- tetrahydro-3-methyl-8-quinolylsulphonyl]-L-arginyl]pipecolic acid (IV). Yield = 93%.

References:

WO2009/124906,2009,A2 Location in patent:Page/Page column 20-21

Argatroban Related Search: